Ordinary Adjustment | Solactive US CNS Therapeutics Index | Effective Date 13th December 2024
Solactive US CNS Therapeutics Index:
In the ordinary adjustment, the following composition will be implemented effective open 13th December 2024:
| ELI LILLY & CO |
| NEW BIOHAVEN |
| NEUMORA THERAPEUTICS ORD |
| BIOGEN INC |
| SUPERNUS PHARMACEUTICALS INC |
| NEUROCRINE BIOSCIENCES INC |
| LONGBOARD PHARMACEUTICALS INC |
| ALKERMES PLC |
| VERTEX PHARMACEUTICALS INC |
| INTRA-CELLULAR THERAPIES INC |
| DENALI THERAPEUTICS INC |
| JAZZ PHARMACEUTICALS PLC |
| XENON PHARMACEUTICALS INC |
| AXSOME THERAPEUTICS INC |
| MIND MEDICINE MINDMED INC |
| AVADEL PHARMACEUTICALS PLC |
| Annexon Inc |
| ACADIA PHARMACEUTICALS INC |
| PROTHENA CORP PLC |
| HARMONY BIOSCIENCES HOLDINGS INC |